N2-(1-carboxyethyl)-2'Deoxyguanosine (CEdG) a Potential Biomarker for Diabetes
Clinical trial NCT02065310 · COMPLETED
Trial details
- NCT number
- NCT02065310
- Sponsor
- City of Hope Medical Center
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2014-10-01
- Primary completion
- 2019-02-11
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.